ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
다우존스 지수
43,487.83
0.78%
Bitcoin
106,798.06
3.57%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Biotech Acquisition Company (BIOT)

  7. Biotech Acquisition Company (BIOT) 뉴스

BIOT

Biotech Acquisition (BIOT)

Biotech Acquisition Company
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BIOT
일자시간출처헤드라인심볼기업
2023/02/1507:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:BIOTBiotech Acquisition Company
2023/02/1404:12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOTBiotech Acquisition Company
2023/02/0306:56Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:BIOTBiotech Acquisition Company
2023/02/0220:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
2023/01/2803:19Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOTBiotech Acquisition Company
2023/01/2602:14Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOTBiotech Acquisition Company
2023/01/1123:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
2023/01/0507:51PR Newswire (US)Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension AmendmentNASDAQ:BIOTBiotech Acquisition Company
2023/01/0505:20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOTBiotech Acquisition Company
2022/11/2220:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOTBiotech Acquisition Company
2022/11/1503:44Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:BIOTBiotech Acquisition Company
2022/10/1205:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
2022/08/2305:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOTBiotech Acquisition Company
2022/08/0121:00Business WireBlade Therapeutics to Participate in “Drug Development in Pulmonary Medicine” Panel Discussion at 2022 BTIG Biotechnology ConferenceNASDAQ:BIOTBiotech Acquisition Company
2022/06/1805:06Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:BIOTBiotech Acquisition Company
2022/06/1805:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
2022/06/1321:06PR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination AgreementNASDAQ:BIOTBiotech Acquisition Company
2022/06/0319:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
2022/06/0319:03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
2022/06/0309:58PR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business CombinationNASDAQ:BIOTBiotech Acquisition Company
2022/05/3121:18Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
2022/05/3121:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
2022/05/3120:30PR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business CombinationNASDAQ:BIOTBiotech Acquisition Company
2022/05/2422:30Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
2022/05/2422:13PR Newswire (US)Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.NASDAQ:BIOTBiotech Acquisition Company
2022/05/2405:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
2022/05/2005:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
2022/05/1905:21Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
2022/05/1905:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
2022/05/1822:01Business WireBlade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International ConferenceNASDAQ:BIOTBiotech Acquisition Company
 검색 관련기사 보기:NASDAQ:BIOT

최근 히스토리

BOV
CRIV4L
ALFA FINANC PN
BIT
COV
Cover 50
SUSHI
TRXCETH
TronClassic
USOTC
MYLKF
Planting Hope (PK)
NASDAQ
VWE
Vintage Wine Estates
LSE
PI00
Bp Cap. 36
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유